Chimovits Erez Insider Trades & Stock Holdings
Chimovits Erez, Director at ADARx Pharmaceuticals, Inc. has 1 Form 4 trade on file since Sep 28, 2026. Open-market activity: 1 purchase ($1.05M) and 0 sales ($0), net +$1.05M. Latest filing: acquired 61.52K shares of $ADRX on Sep 28, 2026 at $17.
- Trades on file
- 1
- Open-market bought
- $1.05M
- Open-market sold
- $0
- Net open-market
- +$1.05M
- Latest filing
- Sep 28, 2026
All insider trades by Chimovits Erez
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ADRX | Buy (Open-market buy) | 61.52K | $17 | $1.05M | Director | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Chimovits Erez traded
Frequently asked questions
Has Chimovits Erez been buying or selling stock?
Chimovits Erez has 1 open-market purchase and 0 open-market sales on file, net +$1.05M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Chimovits Erez's latest insider trade?
acquired 61.52K shares of $ADRX on Sep 28, 2026 at $17.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.